Nifty
Sensex
:
:
11873.05
40431.60
110.60 (0.94%)
448.62 (1.12%)

Pharmaceuticals & Drugs - Global

Rating :
61/99  (View)

BSE: 506197 | NSE: BLISSGVS

174.70
-0.15 (-0.09%)
19-Oct-2020 | 3:55PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  174.95
  •  175.40
  •  172.95
  •  174.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  393894
  •  688.13
  •  181.60
  •  81.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,804.55
  • 22.65
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,822.19
  • 0.29%
  • 2.40

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 41.60%
  • 13.32%
  • 14.44%
  • FII
  • DII
  • Others
  • 23.96%
  • 2.92%
  • 3.76%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.16
  • 4.74
  • -5.42

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.69
  • -4.57
  • -8.97

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.12
  • 3.35
  • 18.28

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.29
  • 18.88
  • 18.25

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.76
  • 2.99
  • 2.59

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.07
  • 8.72
  • 8.14

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
130
212
-39%
120
244
-51%
148
220
-33%
210
228
-8%
Expenses
110
163
-32%
104
212
-51%
115
177
-35%
185
187
-1%
EBITDA
19
49
-60%
16
32
-50%
33
44
-24%
25
42
-39%
EBIDTM
15%
23%
14%
13%
22%
20%
12%
18%
Other Income
7
2
234%
17
3
495%
6
-4
-
13
25
-48%
Interest
2
1
106%
2
1
157%
1
1
12%
1
1
-17%
Depreciation
4
3
55%
3
2
52%
3
2
36%
4
2
50%
PBT
20
47
-57%
13
32
-58%
34
36
-6%
34
63
-46%
Tax
4
14
-73%
8
13
-39%
9
9
-3%
3
21
-86%
PAT
17
33
-50%
6
19
-70%
25
27
-7%
31
42
-26%
PATM
13%
16%
7%
8%
17%
12%
15%
18%
EPS
1.61
3.24
-50%
0.54
1.82
-70%
2.47
2.64
-6%
2.99
4.04
-26%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
607
689
898
815
798
547
407
345
397
267
219
Net Sales Growth
-33%
-23%
10%
2%
46%
34%
18%
-13%
49%
22%
 
Cost Of Goods Sold
4,961
440
612
391
359
237
153
132
168
146
112
Gross Profit
-4,354
249
286
424
440
310
254
213
229
121
107
GP Margin
-717%
36%
32%
52%
55%
57%
62%
62%
58%
45%
49%
Total Expenditure
514
566
741
618
596
391
304
273
285
196
160
Power & Fuel Cost
-
6
5
5
6
5
4
3
2
1
1
% Of Sales
-
1%
1%
1%
1%
1%
1%
1%
1%
0%
0%
Employee Cost
-
54
42
69
61
34
29
23
15
6
4
% Of Sales
-
8%
5%
8%
8%
6%
7%
7%
4%
2%
2%
Manufacturing Exp.
-
6
5
5
5
26
30
41
37
13
16
% Of Sales
-
1%
1%
1%
1%
5%
7%
12%
9%
5%
7%
General & Admin Exp.
-
13
17
39
36
25
17
15
15
7
5
% Of Sales
-
2%
2%
5%
5%
5%
4%
4%
4%
3%
2%
Selling & Distn. Exp.
-
29
35
62
92
43
47
35
40
21
16
% Of Sales
-
4%
4%
8%
12%
8%
12%
10%
10%
8%
7%
Miscellaneous Exp.
-
18
24
45
36
23
23
23
8
1
16
% Of Sales
-
3%
3%
6%
4%
4%
6%
7%
2%
1%
3%
EBITDA
94
123
158
197
203
156
103
71
111
71
59
EBITDA Margin
15%
18%
18%
24%
25%
28%
25%
21%
28%
27%
27%
Other Income
42
37
38
27
13
24
20
28
14
16
2
Interest
6
5
4
23
20
19
16
18
10
4
2
Depreciation
14
13
9
21
20
13
11
11
6
4
5
PBT
102
142
182
179
175
148
96
71
109
79
53
Tax
23
34
55
57
63
48
35
30
50
27
12
Tax Rate
23%
26%
30%
39%
36%
32%
36%
42%
46%
34%
23%
PAT
79
97
124
59
82
82
60
41
58
53
41
PAT before Minority Interest
76
95
127
89
113
100
61
41
60
53
41
Minority Interest
-2
2
-3
-30
-31
-18
-1
0
-2
0
0
PAT Margin
13%
14%
14%
7%
10%
15%
15%
12%
15%
20%
19%
PAT Growth
-35%
-21%
110%
-28%
-1%
38%
46%
-29%
10%
29%
 
EPS
7.62
9.43
12.00
5.70
7.96
8.00
5.81
3.98
5.60
5.10
3.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
736
646
536
487
413
337
287
258
211
167
Share Capital
10
10
10
10
10
10
10
10
10
10
Total Reserves
725
636
526
476
402
327
277
248
200
156
Non-Current Liabilities
46
38
13
33
50
68
96
97
39
4
Secured Loans
37
33
6
26
30
55
79
90
38
4
Unsecured Loans
0
0
0
0
9
2
9
1
0
0
Long Term Provisions
2
2
2
2
2
1
1
1
1
1
Current Liabilities
232
207
299
437
379
243
308
202
60
43
Trade Payables
94
79
58
98
108
80
82
118
40
31
Other Current Liabilities
55
50
124
100
53
70
42
24
6
4
Short Term Borrowings
66
64
106
187
62
61
57
45
6
3
Short Term Provisions
17
14
11
51
156
31
126
14
8
4
Total Liabilities
1,029
905
860
1,023
874
662
700
571
310
213
Net Block
241
145
136
304
225
234
213
168
40
20
Gross Block
276
170
157
327
301
294
262
206
64
41
Accumulated Depreciation
35
25
21
23
75
59
49
38
24
21
Non Current Assets
256
211
170
457
291
245
230
220
100
57
Capital Work in Progress
0
47
0
4
9
0
4
1
7
8
Non Current Investment
1
1
6
1
0
0
0
0
0
0
Long Term Loans & Adv.
13
18
27
11
57
10
12
51
53
29
Other Non Current Assets
1
0
0
137
0
0
0
0
0
0
Current Assets
773
694
690
566
583
417
469
349
210
157
Current Investments
0
0
0
0
0
0
0
0
1
0
Inventories
74
77
59
49
39
34
33
33
13
12
Sundry Debtors
548
461
298
254
301
247
215
245
129
120
Cash & Bank
103
107
89
150
78
57
80
50
58
18
Other Current Assets
48
19
97
33
165
79
141
21
9
7
Short Term Loans & Adv.
31
29
146
78
150
61
130
9
5
3
Net Current Assets
541
487
390
129
204
174
162
147
150
114
Total Assets
1,029
905
860
1,023
874
662
700
571
310
213

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
45
40
18
289
113
49
41
6
35
0
PBT
129
182
179
175
148
96
71
109
79
0
Adjustment
24
-11
18
36
18
22
24
10
5
0
Changes in Working Capital
-69
-183
-141
113
-8
-61
-19
-74
-38
0
Cash after chg. in Working capital
84
-12
56
325
158
58
75
45
46
0
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-39
52
-39
-36
-45
-9
-34
-39
-11
0
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-49
-74
50
-231
-50
-39
-11
-124
-22
0
Net Fixed Assets
-66
-52
-1
42
-5
-29
-13
-13
-17
Net Investments
0
0
2
-1
-1
0
0
-18
-1
Others
17
-21
49
-272
-43
-10
2
-93
-4
Cash from Financing Activity
-4
17
-76
-10
-40
-43
-8
110
26
0
Net Cash Inflow / Outflow
-8
-17
-8
48
23
-33
22
-8
40
0
Opening Cash & Equivalents
15
37
47
0
5
50
28
58
18
0
Closing Cash & Equivalent
15
15
37
47
28
16
50
50
58
0

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
71
63
52
47
40
33
28
25
20
16
ROA
10%
14%
9%
12%
13%
9%
6%
14%
20%
19%
ROE
14%
21%
17%
25%
27%
20%
15%
26%
28%
24%
ROCE
17%
27%
25%
31%
32%
24%
21%
36%
39%
32%
Fixed Asset Turnover
3.09
5.49
3.37
2.56
1.85
1.47
1.48
2.95
5.09
5.37
Receivable days
267
154
124
126
182
206
242
171
169
199
Inventory Days
40
28
24
20
24
30
34
21
17
19
Payable days
58
35
52
68
95
109
149
105
68
74
Cash Conversion Cycle
249
147
96
79
111
127
127
87
118
145
Total Debt/Equity
0.16
0.16
0.22
0.46
0.32
0.47
0.60
0.58
0.21
0.05
Interest Cover
25
42
7
10
9
7
5
12
21
26

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.